Follow
Marina Lorente-Picon
Marina Lorente-Picon
Unknown affiliation
Verified email at vhir.org
Title
Cited by
Cited by
Year
New avenues for Parkinson’s disease therapeutics: disease-modifying strategies based on the gut microbiota
M Lorente-Picón, A Laguna
Biomolecules 11 (3), 433, 2021
482021
In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
M Gonzalez-Sepulveda, J Compte, T Cuadros, A Nicolau, ...
Brain 146 (3), 1040-1052, 2023
122023
Activity of NADH‐and FADH2‐linked mitochondrial respiration are significantly decreased in two mice models of Parkinson’s disease
J Soliz, ML Picón, HH Doucet-Beaupré, M Levesque, S Laouafa
The FASEB Journal 34 (S1), 1-1, 2020
12020
Neuroprotective effect of stomatin-like protein 2 overexpression in A53T-a-synuclein parkinson disease mice model
M Lorente Picon
12020
Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related multisystem neurodegenerative deficits
A Laguna, N Peñuelas, M Gonzalez-Sepulveda, A Nicolau, S Arthaud, ...
bioRxiv, 2023.08. 08.552400, 2023
2023
SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models
MPC Rueda, G Gentile, A Zanon, A Lavdas, C Bolduc, ML Picón, ...
International Congress of Parkinson’s Disease and Movement Disorders, 2023
2023
Modulation of SLP-2 expression protects against alpha-synuclein neuropathology by mitigating mitochondrial dysfunction
MP Castelo-Rueda, G Gentile, A Zanon, A Lavdas, C Bolduc, ML Picón, ...
Cell Symposia: Multifaceted Mitochondria, 2022
2022
SLP-2 protects SNpc DA neurons against alpba-synuclein toxicity by rescuing mitochondrial functions in a mouse model of Parkinson's disease
C Bolduc, ML Picon, S Laouafa, J Soliz, G Gentile, MP Castelo-Rueda, ...
Keystone Symposia, 2022
2022
Age-dependent multisystem parkinsonian features in a novel neuromelanin-producing transgenic mouse model
N Peñuelas, A Laguna, M González-Sepúlveda, L Miquel-Rio, H Xicoy, ...
2021
Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson's Disease
C Bolduc, ML Picon, S Laouafa, J Soliz, I Pichler, M Levesque
MOVEMENT DISORDERS 36, S204-S204, 2021
2021
NEUROPROTECTIVE EFFECT OF STOMATIN-LIKE PROTEIN 2 OVEREXPRESSION IN A53T-α-SYNUCLEIN PARKINSON’S DISEASE MICE MODEL
M Lorente-Picon, H Doucet-Beaupré, A Zanon, S Meschini, M Parent, ...
5th World Parkinson Congress, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–11